Andersson BS, Thall PF, Ma J, Valdez BC, et al. A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan +/- clofarabine in allogeneic stem cell transplantation. Bone Marrow Transplant 2022 May 24. pii: 10.1038/s41409-022-01705.
PMID: 35610308